Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA-STAT: Aspirin and Simvastatin in PAH
NCT00384865Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Sep 2006
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin and simvastatin in pulmonary arterial hypertension (PAH) (4 arms), sponsored by University of Pennsylvania. Primary endpoint: Distance Walked in Six Minutes at 6 months. Started Sep 2006; status: terminated.
02
Drugs
aspirinsimvastatin
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00384865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384865.